Skip to main navigation Skip to search Skip to main content

Histone deacetylase inhibitors: The anticancer, antimetastatic and antiangiogenic activities of AN-7 are superior to those of the clinically tested AN-9 (Pivanex)

  • Nataly Tarasenko
  • , Abraham Nudelman
  • , Igor Tarasenko
  • , Michal Entin-Meer
  • , Daphne Hass-Kogan
  • , Aida Inbal
  • , Ada Rephaeli*
  • *Corresponding author for this work
  • Tel Aviv University
  • Bar-Ilan University
  • University of California at San Francisco
  • Rabin Medical Center Israel

Research output: Contribution to journalArticlepeer-review

38 Scopus citations

Fingerprint

Dive into the research topics of 'Histone deacetylase inhibitors: The anticancer, antimetastatic and antiangiogenic activities of AN-7 are superior to those of the clinically tested AN-9 (Pivanex)'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science